randomized, double-blinded, phase 2 trial of different dosing strategies for the treatment of adults living with chronic Chagas disease: The MULTIBENZ study

被引：0
|
作者：
Bosch-Nicolau, Pau [5 ]
Fernandez, Marisa [6 ]
Villar, Juan Carlos [1 ]
Ribeiro, Antonio [2 ]
Sulleiro, Elena [5 ]
Bangher, Maria [3 ]
Herrera, Eliana Vaquiro [1 ]
Moreira, Otacilio [4 ]
Molina, Israel [5 ]
机构：
[1] Fdn Cardioinfantil, Inst Cardiol, Bogota, Colombia
[2] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
[3] Inst Cardiol Corrientes Juana Francisca Cabra, Corrientes, Argentina
[4] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil
[5] Univ Hosp Vall dHebron, Barcelona, Spain
[6] Hosp Enfermedades Infecc Dr Francisco J Muniz, Buenos Aires, DF, Argentina
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
288
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [1] Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ) : an international, randomised, double-blind, phase 2b trial
    Bosch-Nicolau, Pau
    Fernandez, Marisa L.
    Sulleiro, Elena
    Villar, Juan Carlos
    Perez-Molina, Jose A.
    Correa-Oliveira, Rodrigo
    Sosa-Estani, Sergio
    Sanchez-Montalva, Adridn
    Bangher, Maria del Carmen
    Moreira, Otacilio C.
    Salvador, Fernando
    Ferreira, Ariela Mota
    Eloi-Santos, Silvana Maria
    Serre-Delcor, Nuria
    Ramirez, Juan Carlos
    Silgado, Aroa
    Oliveira, Ines
    Martin, Oihane
    Aznar, Maria Luisa
    Ribeiro, Antonio Luiz P.
    Almeida, Paulo Emilio Clementino
    Chamorro-Tojeiro, Sandra
    Espinosa-Pereiro, Juan
    de Paula, Alfredo Mauricio Batista
    Vaquiro-Herrera, Eliana
    Tur, Carmen
    Molina, Israel
    LANCET INFECTIOUS DISEASES, 2024, 24 (04): : 386 - 394
  • [2] Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial (vol 24, pg 386, 2024)
    Bosh-Nicolau, P.
    Fernandez, M. L.
    Sulleiro, E.
    LANCET INFECTIOUS DISEASES, 2024, 24 (04): : e221 - e221
  • [3] Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial
    D. Molina-Morant
    M. L. Fernández
    P. Bosch-Nicolau
    E. Sulleiro
    M. Bangher
    F. Salvador
    A. Sanchez-Montalva
    A. L. P. Ribeiro
    A. M. B. de Paula
    S. Eloi
    R. Correa-Oliveira
    J. C. Villar
    S. Sosa-Estani
    I. Molina
    Trials, 21
  • [4] Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial
    Molina-Morant, D.
    Fernandez, M. L.
    Bosch-Nicolau, P.
    Sulleiro, E.
    Bangher, M.
    Salvador, F.
    Sanchez-Montalva, A.
    Ribeiro, A. L. P.
    de Paula, A. M. B.
    Eloi, S.
    Correa-Oliveira, R.
    Villar, J. C.
    Sosa-Estani, S.
    Molina, I.
    TRIALS, 2020, 21 (01)
  • [5] Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial
    D. Molina-Morant
    M. L. Fernández
    P. Bosch-Nicolau
    E. Sulleiro
    M. Bangher
    F. Salvador
    A. Sanchez-Montalva
    A. L. P. Ribeiro
    A. M. B. de Paula
    S. Eloi
    R. Correa-Oliveira
    J. C. Villar
    S. Sosa-Estani
    I. Molina
    Trials, 24
  • [6] Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial (vol 21, 328, 2020)
    Molina-Morant, D.
    Fernandez, M. L.
    Bosch-Nicolau, P.
    Sulleiro, E.
    Bangher, M.
    Salvador, F.
    Sanchez-Montalva, A.
    Ribeiro, A. L. P.
    de Paula, A. M. B.
    Eloi, S.
    Correa-Oliveira, R.
    Villar, J. C.
    Sosa-Estani, S.
    Molina, I.
    TRIALS, 2023, 24 (01)
  • [7] Botulinum toxin trial treatment for MS- tremor: a randomized, double-blinded study
    Noffs, G.
    Boonstra, F. M. C.
    Perera, T.
    Kolbe, S.
    Evans, A.
    Merlo, D.
    Sanfilippo, P.
    Butzkueven, H.
    Van der Walt, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 663 - 664
  • [8] Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease
    Rossi, Fabio H.
    Kambara, Antonio M.
    Izukawa, Nilo M.
    Rodrigues, Thiago O.
    Rossi, Cybelle B.
    Sousa, Amanda G.
    Metzger, Patrick B.
    Thorpe, Patricia E.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2018, 6 (02) : 183 - 191
  • [9] Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies
    Jain, Pankaj
    Silva-De Las Salas, Alejandra
    Bedi, Kabir
    Lamelas, Joseph
    Epstein, Richard H.
    Fabbro II, Michael
    ANESTHESIOLOGY, 2025, 142 (01) : 98 - 106
  • [10] Evaluation of Botox treatment in patients with chronic scrotal pain: Protocol for a randomized double-blinded control trial
    Schiellerup, Nicolai Skov
    Kobbero, Hanne
    Andersen, Karin
    Poulsen, Charlotte Aaberg
    Poulsen, Mads Hvid
    BJUI COMPASS, 2024, 5 (06): : 541 - 547
12345